JP2023107883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023107883A5 JP2023107883A5 JP2023096692A JP2023096692A JP2023107883A5 JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5 JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- composition
- surgery
- glp
- parenteral nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762582055P | 2017-11-06 | 2017-11-06 | |
| US62/582,055 | 2017-11-06 | ||
| JP2020526107A JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Division JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023107883A JP2023107883A (ja) | 2023-08-03 |
| JP2023107883A5 true JP2023107883A5 (https=) | 2024-03-06 |
| JP7752152B2 JP7752152B2 (ja) | 2025-10-09 |
Family
ID=66332372
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
| JP2023096692A Active JP7752152B2 (ja) | 2017-11-06 | 2023-06-13 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのｇｌｐ－２類似体及びｇｌｐ－２ペプチボディ |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11660328B2 (https=) |
| EP (1) | EP3706774A4 (https=) |
| JP (2) | JP7296958B2 (https=) |
| KR (1) | KR102825098B1 (https=) |
| CN (1) | CN111629745A (https=) |
| AR (1) | AR113835A1 (https=) |
| AU (1) | AU2018360744A1 (https=) |
| BR (1) | BR112020008936A2 (https=) |
| CA (1) | CA3079523A1 (https=) |
| IL (1) | IL274098B2 (https=) |
| MX (1) | MX2020004620A (https=) |
| TW (1) | TWI911137B (https=) |
| WO (1) | WO2019090209A1 (https=) |
| ZA (1) | ZA202002080B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020003736A2 (pt) * | 2017-08-22 | 2020-09-08 | Shire-Nps Pharmaceuticals, Inc. | polipeptídeos de fusão de glp-2 e usos para tratar e prevenir condições gastrointestinais |
| JP2022512688A (ja) * | 2018-10-24 | 2022-02-07 | シャイア－エヌピーエス ファーマシューティカルズ インコーポレイテッド | Ｇｌｐ－２融合ポリペプチドならびに消化管の状態の処置および予防のための使用 |
| SG11202111311WA (en) | 2019-06-14 | 2021-12-30 | Zealand Pharma As | Pharmaceutical parenteral composition of dual glp1/2 agonist |
| KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
| TW202140440A (zh) | 2020-02-28 | 2021-11-01 | 美商克力歐普股份有限公司 | Gpr40激動劑 |
| US20230129788A1 (en) * | 2020-03-30 | 2023-04-27 | Zealand Pharma A/S | Glp-1/glp-2 dual agonists |
| WO2021236617A1 (en) | 2020-05-19 | 2021-11-25 | Kallyope, Inc. | Ampk activators |
| CN116390925A (zh) | 2020-06-26 | 2023-07-04 | 卡尔优普公司 | Ampk活化剂 |
| WO2021263040A1 (en) * | 2020-06-26 | 2021-12-30 | Shire-Nps Pharmaceuticals, Inc. | Stable peptibody formulations |
| CN115636876A (zh) * | 2021-07-20 | 2023-01-24 | 重庆派金生物科技有限公司 | 胰高血糖素样肽-2突变体的定向化学偶联物及其应用 |
| CN117467025B (zh) * | 2023-12-28 | 2024-04-16 | 上海鼎新基因科技有限公司 | 一种抗vegf和补体双功能融合蛋白及其应用 |
| WO2025181330A1 (en) * | 2024-02-29 | 2025-09-04 | Vectivbio Ag | Dosage regimens for glucagon-like peptide 2 (glp-2) analogs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1809318B1 (en) | 2004-11-01 | 2013-06-12 | NPS Pharmaceuticals, Inc. | Treatment of short bowel syndrome patients with colon-in-continuity |
| JP2009510999A (ja) | 2005-07-29 | 2009-03-19 | エーエムプロテイン コーポレイション | キメラ治療剤 |
| EA200801174A1 (ru) * | 2005-10-24 | 2009-02-27 | Сентокор, Инк. | Антитела-миметики glp-2, полипептиды, композиции, способы и применения |
| JP5290177B2 (ja) | 2006-08-31 | 2013-09-18 | セントカー・インコーポレーテツド | Ｇｌｐ−２ミメティボディ、ポリペプチド、組成物、方法および用途 |
| JP2008247789A (ja) | 2007-03-30 | 2008-10-16 | Kissei Pharmaceut Co Ltd | クローン病に伴う腸管狭窄の進展抑制用医薬組成物 |
| JP6206972B2 (ja) | 2011-09-12 | 2017-10-04 | アムニクス オペレーティング インコーポレイテッド | グルカゴン様ペプチド−２組成物およびその作製法および使用法 |
| UY34347A (es) * | 2011-09-26 | 2013-04-30 | Novartis Ag | Proteínas de función dual para tratar trastornos metabólicos |
| KR101895047B1 (ko) | 2011-12-30 | 2018-09-06 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체 |
| CN104540850B (zh) | 2012-05-03 | 2018-05-18 | 西兰制药公司 | 胰高血糖素样肽2(glp-2)类似物 |
| EP3082847A1 (en) * | 2013-12-20 | 2016-10-26 | Indiana University Research and Technology Corporation | Lipidated incretin receptor ligand human immunoglobulin fc-region fusion polypeptides |
| KR101825048B1 (ko) * | 2014-12-31 | 2018-02-05 | 주식회사 제넥신 | GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도 |
-
2018
- 2018-11-05 WO PCT/US2018/059175 patent/WO2019090209A1/en not_active Ceased
- 2018-11-05 CN CN201880071791.3A patent/CN111629745A/zh active Pending
- 2018-11-05 EP EP18872377.9A patent/EP3706774A4/en active Pending
- 2018-11-05 CA CA3079523A patent/CA3079523A1/en active Pending
- 2018-11-05 JP JP2020526107A patent/JP7296958B2/ja active Active
- 2018-11-05 AU AU2018360744A patent/AU2018360744A1/en not_active Abandoned
- 2018-11-05 US US16/761,606 patent/US11660328B2/en active Active
- 2018-11-05 KR KR1020207013387A patent/KR102825098B1/ko active Active
- 2018-11-05 BR BR112020008936-2A patent/BR112020008936A2/pt unknown
- 2018-11-05 IL IL274098A patent/IL274098B2/en unknown
- 2018-11-05 MX MX2020004620A patent/MX2020004620A/es unknown
- 2018-11-06 AR ARP180103232A patent/AR113835A1/es unknown
- 2018-11-06 TW TW107139266A patent/TWI911137B/zh active
-
2020
- 2020-05-04 ZA ZA2020/02080A patent/ZA202002080B/en unknown
-
2023
- 2023-06-13 JP JP2023096692A patent/JP7752152B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023107883A5 (https=) | ||
| IL274098B2 (en) | Glp-2 analogs and peptibodies for administration before during, or after surgery | |
| Lever | Methotrexate and prednisone in pemphigus vulgaris: therapeutic results obtained in 36 patients between 1961 and 1970 | |
| Buchwald et al. | Ileal bypass in patients with hypercholesterolemia and atherosclerosis: preliminary report on therapeutic potential | |
| Sharma et al. | Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies | |
| JP2021502389A5 (https=) | ||
| Braier et al. | Symptomatic bone langerhans cell histiocytosis treated at diagnosis or after reactivation with indomethacin alone | |
| Halloun et al. | Bariatric surgery in adolescents with obesity: long-term perspectives and potential alternatives | |
| JP2019112416A5 (https=) | ||
| Hermann | Acquired Brown's syndrome of inflammatory origin: response to locally injected steroids | |
| Sticherling | Systemic sclerosis–the dermatological perspective | |
| Miyata et al. | Efficacy of Benralizumab and Clinical Course of Igg4 on Eosinophilic | |
| McCarty et al. | Azathioprine as a steroid-sparing agent in radiation pneumonitis | |
| Han et al. | Management of eosinophilic granuloma occurring in the appendicular skeleton in children | |
| WO2020200305A1 (zh) | 一种含羟基脲的药物组合物的应用 | |
| Pelz et al. | A case of pre-chronic paroxysmal hemicrania | |
| Shah et al. | Sinus node dysfunction secondary to hyperparathyroidism | |
| Tham et al. | Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer | |
| Ozaki et al. | Manifestation of latent left ventricular outflow tract obstruction caused by acute myocardial infarction: an important complication of acute myocardial infarction | |
| Hanna et al. | Efficacy and complications of intravesical BCG in immunocompromised patients | |
| Katsube et al. | Interposition grafting of collagen-gelatin sponge impregnated with basic fibroblast growth factor in primary palatoplasty | |
| Syngle | Arthritis and its treatment | |
| Kaddioui et al. | Pansclerotic morphea: a historical case in children | |
| Greenberg et al. | Current and emerging multiple sclerosis therapeutics | |
| Elbrønd et al. | Circinoma Linguae: A series of 96 patients |